Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi’s Sarcoma-Associated Herpesvirus Latent and Lytic Replications

Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi’s Sarcoma-Associated Herpesvirus Latent and Lytic Replications

ABSTRACT Oncogenic Kaposi’s sarcoma-associated herpesvirus (KSHV) is etiologically linked to primary effusion lymphoma (PEL), an aggressive and nontreatable malignancy commonly found in AIDS patients. In this study, we performed a high-throughput screening of 3,731 characterized compounds and identi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marion Gruffaz, Shenghua Zhou, Karthik Vasan, Teresa Rushing, Qing Liu Michael, Chu Lu, Jae U. Jung, Shou-Jiang Gao
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2018
Materias:
cytarabine
DNA/RNA syntheses
inhibition of latent and lytic replication
KSHV
latency-associated nuclear antigen (LANA) degradation
primary effusion lymphoma
Microbiology
QR1-502
Acceso en línea:https://doaj.org/article/813532cf3c73482aa2786bdbec28fc9f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/813532cf3c73482aa2786bdbec28fc9f

Ejemplares similares